CAM
Crestone Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,224
| Closed | -$288K | – | 117 |
|
|
2023
Q4 | $288K | Sell |
3,224
-6,040
| -65% | -$539K | 0.07% | 75 |
|
|
2023
Q3 | $676K | Sell |
9,264
-5,651
| -38% | -$413K | 0.16% | 50 |
|
|
2023
Q2 | $1.24M | Sell |
14,915
-52
| -0.3% | -$4.33K | 0.27% | 47 |
|
|
2023
Q1 | $1.14M | Sell |
14,967
-6,708
| -31% | -$511K | 0.24% | 46 |
|
|
2022
Q4 | $1.8M | Sell |
21,675
-12,066
| -36% | -$1M | 0.38% | 36 |
|
|
2022
Q3 | $2.68M | Sell |
33,741
-47,722
| -59% | -$3.78M | 0.68% | 29 |
|
|
2022
Q2 | $6.05M | Buy |
81,463
+10,846
| +15% | +$805K | 1.42% | 19 |
|
|
2022
Q1 | $6.35M | Buy |
70,617
+62,845
| +809% | +$5.65M | 1.33% | 21 |
|
|
2021
Q4 | $870K | Sell |
7,772
-1,236
| -14% | -$138K | 0.18% | 46 |
|
|
2021
Q3 | $1.13M | Sell |
9,008
-2,377
| -21% | -$299K | 0.25% | 43 |
|
|
2021
Q2 | $1.54M | Sell |
11,385
-4,763
| -29% | -$645K | 0.33% | 37 |
|
|
2021
Q1 | $2.19M | Sell |
16,148
-305
| -2% | -$41.4K | 0.57% | 25 |
|
|
2020
Q4 | $2.32M | Sell |
16,453
-6,479
| -28% | -$912K | 0.62% | 26 |
|
|
2020
Q3 | $2.56M | Sell |
22,932
-8,438
| -27% | -$940K | 0.8% | 25 |
|
|
2020
Q2 | $3.51M | Sell |
31,370
-21,560
| -41% | -$2.41M | 1.16% | 22 |
|
|
2020
Q1 | $4.1M | Sell |
52,930
-3,527
| -6% | -$273K | 1.67% | 16 |
|
|
2019
Q4 | $5.37M | Sell |
56,457
-1,137
| -2% | -$108K | 1.82% | 17 |
|
|
2019
Q3 | $4.39M | Buy |
57,594
+2,674
| +5% | +$204K | 1.67% | 18 |
|
|
2019
Q2 | $4.82M | Buy |
54,920
+19,254
| +54% | +$1.69M | 1.69% | 17 |
|
|
2019
Q1 | $3.23M | Buy |
35,666
+4,986
| +16% | +$451K | 1.14% | 23 |
|
|
2018
Q4 | $2.2M | Sell |
30,680
-165
| -0.5% | -$11.8K | 0.83% | 25 |
|
|
2018
Q3 | $2.96M | Buy |
30,845
+19,634
| +175% | +$1.88M | 1.3% | 17 |
|
|
2018
Q2 | $1.07M | Buy |
+11,211
| New | +$1.07M | 0.47% | 26 |
|